ARC Medical Inc files Form D for equity offering of about $117,668
The British Columbia biotechnology company reported selling all of the offered securities to two investors, per a Form D filed with the SEC.
ARC Medical Inc, listed under the entity name ARC Medical Devices Inc., filed a Form D notice of exempt offering with the Securities and Exchange Commission. The filing is marked as a new notice, with a date of first sale of July 24, 2026.1
The company is based in Richmond, British Columbia, Canada, and is incorporated in British Columbia, Canada, more than five years ago.1 The filing lists three related persons: Christopher Springate as an executive officer and director, Bruce Hay as a director, and Deng Mao as a director, all with addresses in Richmond, British Columbia.1
The offering falls under the biotechnology industry group within health care1 and was made under the Rule 506(b) exemption.1 Per the filing, the company does not intend the offering to last more than one year.1 The type of security offered is equity.1
According to the offering and sales amounts section, the total offering amount and total amount sold were each $117,668, with $0 remaining to be sold, based on an exchange rate of C$1.4093 to US$1.00.1 The filing indicates a total of two investors have already invested in the offering.1
The company reported no sales commissions or finders' fees expenses1 and no proceeds used for payments to executive officers, directors, or promoters.1
The notice was signed by Christopher Springate as CEO on August 6, 2026.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.